Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor 12 (TCF12)
- Target
- TCF12
- Molecular classification
- Transcription factor, Basic helix-loop-helix (bHLH) protein, E-protein family
01
Overview
Transcription factor 12 (TCF12) is a member of the basic helix-loop-helix (bHLH) E-protein family that binds to E-box sequences (CANNTG) on DNA, acting as a transcriptional regulator critical in cell fate decisions by controlling lineage-specific gene expression. TCF12 forms heterodimers with other bHLH proteins such as MYOD, TWIST1, and TCF21, modulating chromatin structure and expression of muscle, neuronal, and hematopoietic genes. It is implicated in embryogenesis, muscle regeneration, neuronal development, and hematopoiesis; its altered function is associated with craniosynostosis, several cancers (where it can act contextually as an oncogene or tumor suppressor), and neurodevelopmental and hematologic disorders. Loss-of-function mutations in TCF12 are linked to craniosynostosis and GnRH neuron development defects, while dysregulation affects metastasis, immune cell development, and stem cell differentiation.
- Other names
- HEBHTF4bHLHb20p64DNA-binding protein HTF4E-box-binding proteinHelix-loop-helix transcription factor 4CRS3HH26HsT17266
02
Biological functions
Regulation of lineage-specific gene expressionChromatin remodelingCell fate determinationMuscle stem cell proliferation and differentiationInitiation of neuronal differentiationT cell/B cell developmentHematopoietic stem cell differentiation
03
Disease associations
Cancer (colorectal, ovarian, cervical, lung, glioma, prostate among others)CraniosynostosisHypogonadotropic hypogonadismNeurodevelopmental disorders (dyslexia, GnRH axis, etc.)Myeloid disorders/Leukemia
04
Safety considerations
Lack of target selectivityPotential for off-target effectsUnintended modulation of normal tissue development and function
05
Biomarkers
TCF12 mutation and expression levelsTCF12/E-box target gene signatures
Beyond the preview
Go deeper on Transcription factor 12 (TCF12).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Transcription factor 12 (TCF12).